- Home
- Labeler Index
- Sanofi-aventis U.s. Llc
- 0024-5903
- NDC Crossover: 0024-5903 Praluent
NDC Crossover 0024-5903 Praluent
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Alirocumab
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 0024-5903 – Praluent, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Praluent
- OR Generic name: Alirocumab
- AND the same Administration Route: subcutaneous
- OR Dosage Form: injection, solution
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0024-5901 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5902 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
0024-5904 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Sanofi-aventis U.s. Llc | Human Prescription Drug |
61755-020 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Regeneron Pharmaceuticals, Inc. | Human Prescription Drug |
61755-021 | Praluent | Alirocumab | Injection, Solution | Subcutaneous | Regeneron Pharmaceuticals, Inc. | Human Prescription Drug |